OMB.report

Federal forms, ICRs, and supporting documents

Information Collection Request

Verona Integron-Encoded Metallo-β-Lactamase (VIM)-Producing Carbapenem-Resistant Pseudomonas aeruginosa Infections Associated with Invasive Medical Procedures in Tijuana, Mexico

ICR 201903-0920-005 · OMB 0920-1253 · Historical Active

Forms and Documents
DocumentTypeStatusAvailability
SURVEY: Verona Integron-Encoded Metallo--Lactamase (VIM)-Producing Carbapenem-Resistant Pseudomonas aeruginosa Infections Associated with Invasive Medical Procedures in Tijuana, Mexico Form and Instruction New Repair queued
Attachment 3 - Non research determination Tijuana.pdf Supplementary Document Uploaded 2019-03-14 Available
Emergency Review Request Memo Tijuana CRPA.docx Supplementary Document Uploaded 2019-03-14 Available
Emergency SSB Tijana CRPA.docx Supporting Statement B Uploaded 2019-03-14 Available
Emergency SSA Tijuana rev.docx Supporting Statement A Uploaded 2019-03-14 Available
IC Document Collections
IC IDCollectionTypeStatusForm
235350 SURVEY: Verona Integron-Encoded Metallo--Lactamase (VIM)-Producing Carbapenem-Resistant Pseudomonas aeruginosa Infections Associated with Invasive Medical Procedures in Tijuana, Mexico Form and Instruction New
ICR Details
0920-1253 201903-0920-005
Historical Active
HHS/CDC 0920-19AEG
Verona Integron-Encoded Metallo-β-Lactamase (VIM)-Producing Carbapenem-Resistant Pseudomonas aeruginosa Infections Associated with Invasive Medical Procedures in Tijuana, Mexico
New collection (Request for a new OMB Control Number)   No
Emergency 03/18/2019
Approved without change 03/15/2019
Retrieve Notice of Action (NOA) 03/14/2019
  Inventory as of this Action Requested Previously Approved
09/30/2019 6 Months From Approved
197 0 0
66 0 0
0 0 0
Verona integron-encoded metallo-β-lactamase–producing carbapenem-resistant Pseudomonas aeruginosa (VIM-CRPA) and other carbapenemase-producing organisms are an emerging U.S. public health threat due to their high levels of antibiotic resistance and potential for rapid spread in healthcare. Beginning in September 2018, CDC received reports of VIM-CRPA from multiple states through the Antibiotic Resistance Laboratory Network (AR Lab Network). The purpose of this collection is to identify infections among individuals in the U.S. who had surgery at Facility 1 in order to prevent spread of resistance in the U.S. Data will be used to prevent spread of resistance in the U.S. and improve messaging to stem the flow of U.S. patients to Facility 1.
CDC cannot reasonably comply with the normal clearance procedures due to the public harm that is reasonably likely to result if routine processing of this request is required, specifically life-threatening infections in patients exposed to Facility 1, with the potential for further spread and outbreaks in U.S. hospitals where they seek treatment.
US Code: 42 USC 241 Name of Law: U.S. PHSA
  
None
Not associated with rulemaking
No
  Total Approved Previously Approved Change Due to New Statute Change Due to Agency Discretion Change Due to Adjustment in Estimate Change Due to Potential Violation of the PRA
Annual Number of Responses 197 0 0 197 0 0
Annual Time Burden (Hours) 66 0 0 66 0 0
Annual Cost Burden (Dollars) 0 0 0 0 0 0
Yes
Miscellaneous Actions
No
Submission of 0920-19AEG - Verona Integron-Encoded Metallo-β-Lactamase (VIM)-Producing Carbapenem-Resistant Pseudomonas aeruginosa Infections Associated with Invasive Medical Procedures in Tijuana, Mexico is a NEW Emergency Request that is submitted to identify infections among individuals in the U.S. who had surgery at Facility 1 in order to prevent spread of resistance in the U.S.
$11,814
Yes Part B of Supporting Statement
    Yes
    Yes
No
No
No
Uncollected
Jeffrey Zirger 404 639-7118 [email protected]
  No
On behalf of this Federal agency, I certify that the collection of information encompassed by this request complies with 5 CFR 1320.9 and the related provisions of 5 CFR 1320.8(b)(3).
The following is a summary of the topics, regarding the proposed collection of information, that the certification covers:
 
 
 
 
 
 
 
    (i) Why the information is being collected;
    (ii) Use of information;
    (iii) Burden estimate;
    (iv) Nature of response (voluntary, required for a benefit, or mandatory);
    (v) Nature and extent of confidentiality; and
    (vi) Need to display currently valid OMB control number;
 
 
 
If you are unable to certify compliance with any of these provisions, identify the item by leaving the box unchecked and explain the reason in the Supporting Statement.
03/14/2019